Q2ChIP, a Quick and Quantitative Chromatin Immunoprecipitation Assay, Unravels Epigenetic Dynamics of Developmentally Regulated Genes in Human Carcinoma Cells

Chromatin immunoprecipitation (ChIP) is a key technique for studying protein‐DNA interactions and mapping epigenetic histone modifications on DNA. Current ChIP protocols require extensive sample handling and large cell numbers. We developed a quick and quantitative (Q2)ChIP assay suitable for histone and transcription factor immunoprecipitation from chromatin amounts equivalent to as few as 100 cells. DNA‐protein cross‐linking in suspension in presence of butyrate, elimination of background chromatin through a tube shift after washes, and a combination of cross‐link reversal, protein digestion, increased antibody‐bead to chromatin ratio, and DNA elution into a single step considerably improve ChIP efficiency and shorten the procedure. We used Q2ChIP to monitor changes in histone H3 modifications on the 5′ regulatory regions of the developmentally regulated genes OCT4, NANOG, LMNA, and PAX6 in the context of retinoic‐acid‐mediated human embryonal carcinoma cell differentiation. Quantitative polymerase chain reaction analysis of precipitated DNA unravels biphasic heterochromatin assembly on OCT4 and NANOG, involving H3 lysine (K)9 and K27 methylation followed by H3K9 deacetylation and additional H3K27 trimethylation. Di‐ and trimethylation of H3K4 remain relatively unaltered. In contrast, PAX6 displays histone modifications characteristic of repressed genes with potential for activation in undifferentiated cells. PAX6 undergoes H3K9 acetylation and enhanced H3K4 trimethylation upon transcriptional activation. Q2ChIP of the transcription factor Oct4 demonstrates its dissociation from the NANOG promoter upon differentiation. This study is, to our knowledge, the first to reveal histone modification changes on human OCT4 and NANOG regulatory sequences. The results demonstrate ordered chromatin rearrangement on developmentally regulated promoters upon differentiation.

[1]  V. Orlando.  Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.

[2]  P. Laird.  Cancer epigenetics. , 2005, Human molecular genetics.

[3]  Lin Li,et al.  Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. , 2003, Methods.

[4]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[5]  H. Schöler,et al.  Mouse germline restriction of Oct4 expression by germ cell nuclear factor. , 2001, Developmental cell.

[6]  V. Orlando,et al.  Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. , 2000, Trends in biochemical sciences.

[7]  Hans R. Schöler,et al.  New type of POU domain in germ line-specific protein Oct-4 , 1990, Nature.

[8]  H. Schöler,et al.  Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences , 2001, Mammalian Genome.

[9]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[10]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[11]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[12]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[13]  司履生.  Cancer epigenetics , 2006 .

[14]  Stephan Sauer,et al.  Chromatin signatures of pluripotent cell lines , 2006, Nature Cell Biology.

[15]  Stefan Kubicek,et al.  A Crack in Histone Lysine Methylation , 2004, Cell.

[16]  P. Robson,et al.  Transcriptional Regulation of Nanog by OCT4 and SOX2* , 2005, Journal of Biological Chemistry.

[17]  H. Worman,et al.  A-type lamins: Guardians of the soma? , 2004, Nature Cell Biology.

[18]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[19]  P. Collas,et al.  Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. , 2005, Molecular biology of the cell.

[20]  M. Linial,et al.  Culturing neuronal cells on surfaces coated by a novel polyethyleneimine-based polymer. , 2000, Brain research. Brain research protocols.

[21]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[22]  P. Collas,et al.  Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. , 2006, Molecular biology of the cell.

[23]  B. Turner,et al.  Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations , 2006, Nature Genetics.

[24]  B. Turner,et al.  Immunoprecipitation of chromatin. , 1996, Methods in enzymology.

[25]  T. Jenuwein,et al.  The many faces of histone lysine methylation. , 2002, Current opinion in cell biology.

[26]  H. Schöler,et al.  Retinoic acid‐mediated down‐regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. , 1996, The EMBO journal.

[27]  H. Schöler,et al.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. , 1996, Development.

[28]  T. Ian Simpson,et al.  Long-range downstream enhancers are essential for Pax6 expression , 2006, Developmental biology.

[29]  R. B. Redmon,et al.  Identity , 2021, Notre Dame J. Formal Log..

[30]  T. Huang,et al.  Tilling the chromatin landscape: emerging methods for the discovery and profiling of protein-DNA interactions. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[31]  D. Skalnik,et al.  Histone deacetylase activity is required for embryonic stem cell differentiation , 2004, Genesis.

[32]  Xi Chen,et al.  Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells , 2005, Molecular and Cellular Biology.

[33]  A. V. van Puijenbroek,et al.  Characterization of a negative retinoic acid response element in the murine Oct4 promoter , 1994, Molecular and cellular biology.

[34]  H. Cedar,et al.  G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis , 2006, Nature Cell Biology.

[35]  I. Damjanov,et al.  Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[36]  Y. Bergman,et al.  A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells , 1995, Molecular and cellular biology.

[37]  T Ian Simpson,et al.  Pax6; A pleiotropic player in development , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[38]  W. Reik,et al.  Epigenetic reprogramming in mammals. , 2005, Human molecular genetics.

[39]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.